Literature DB >> 17967303

Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy.

Kirsty L Wiltshire1, Kristy K Brock, Masoom A Haider, Daniel Zwahlen, Vickie Kong, Elisa Chan, Joanne Moseley, Andrew Bayley, Charles Catton, Peter W M Chung, Mary Gospodarowicz, Michael Milosevic, Andrew Kneebone, Padraig Warde, Cynthia Ménard.   

Abstract

PURPOSE: We sought to derive and validate an interdisciplinary consensus definition for the anatomic boundaries of the postoperative clinical target volume (CTV, prostate bed). METHODS AND MATERIALS: Thirty one patients who had planned for radiotherapy after radical prostatectomy were enrolled and underwent computed tomography and magnetic resonance imaging (MRI) simulation prior to radiotherapy. Through an iterative process of consultation and discussion, an interdisciplinary consensus definition was derived based on a review of published data, patterns of local failure, surgical practice, and radiologic anatomy. In validation, we analyzed the distribution of surgical clips in reference to the consensus CTV and measured spatial uncertainties in delineating the CTV and vesicourethral anastomosis. Clinical radiotherapy plans were retrospectively evaluated against the consensus CTV (prostate bed).
RESULTS: Anatomic boundaries of the consensus CTV (prostate bed) are described. Surgical clips (n = 339) were well distributed throughout the CTV. The vesicourethral anastomosis was accurately localized using central sagittal computed tomography reconstruction, with a mean +/- standard deviation uncertainty of 1.8 +/- 2.5 mm. Delineation uncertainties were small for both MRI and computed tomography (mean reproducibility, 0-3.8 mm; standard deviation, 1.0-2.3); they were most pronounced in the anteroposterior and superoinferior dimensions and at the superior/posterior-most aspect of the CTV. Retrospectively, the mean +/- standard deviation CTV (prostate bed) percentage of volume receiving 100% of prescribed dose was only 77% +/- 26%.
CONCLUSIONS: We propose anatomic boundaries for the CTV (prostate bed) and present evidence supporting its validity. In the absence of gross recurrence, the role of MRI in delineating the CTV remains to be confirmed. The CTV is larger than historically practiced at our institution and should be encompassed by a microscopic tumoricidal dose.

Entities:  

Mesh:

Year:  2007        PMID: 17967303     DOI: 10.1016/j.ijrobp.2007.04.068

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  34 in total

1.  Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meeting.

Authors:  Michael Sia; Tom Pickles; Gerard Morton; Louis Souhami; Himu Lukka; Padraig Warde
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

2.  Detection of Local Recurrence with 3-Tesla MRI After Radical Prostatectomy: A Useful Method for Radiation Treatment Planning?

Authors:  Daniel Buergy; Metin Sertdemir; Anja Weidner; Mohamed Shelan; Frank Lohr; Frederik Wenz; Stefan O Schoenberg; Ulrike I Attenberger
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

3.  Treatment-related toxicity and symptom-related bother following postoperative radiotherapy for prostate cancer.

Authors:  Michael Sia; George Rodrigues; Cynthia Menard; Andrew Bayley; Robert Bristow; Peter Chung; Mary Gospodarowicz; Michael Milosevic; Padraig Warde; Charles Catton
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

4.  The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.

Authors:  A Karl; A Buchner; C Tympner; T Kirchner; U Ganswindt; C Belka; R Ganzer; M Burger; F Eder; F Hofstädter; D Schilling; K Sievert; A Stenzl; M Scharpf; F Fend; F Vom Dorp; H Rübben; K Schmid; D Porres-Knoblauch; A Heidenreich; B Hangarter; R Knüchel-Clarke; M Rogenhofer; B Wullich; A Hartmann; E Comploj; A Pycha; E Hanspeter; D Pehrke; G Sauter; M Graefen; C Stief; A Haese
Journal:  World J Urol       Date:  2015-02-15       Impact factor: 4.226

5.  Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume?

Authors:  Vivek Verma; Shifeng Chen; Sumin Zhou; Charles A Enke; Andrew O Wahl
Journal:  Strahlenther Onkol       Date:  2016-12-01       Impact factor: 3.621

6.  Asymmetrical Multi-task Attention U-Net for the Segmentation of Prostate Bed in CT Image.

Authors:  Xuanang Xu; Chunfeng Lian; Shuai Wang; Andrew Wang; Trevor Royce; Ronald Chen; Jun Lian; Dinggang Shen
Journal:  Med Image Comput Comput Assist Interv       Date:  2020-09-29

7.  Target volume definition for post prostatectomy radiotherapy: Do the consensus guidelines correctly define the inferior border of the CTV?

Authors:  Mo Manji; Juanita Crook; Matt Schmid; Rasika Rajapakshe
Journal:  Rep Pract Oncol Radiother       Date:  2016-09-01

8.  Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.

Authors:  Jeff M Michalski; Colleen Lawton; Issam El Naqa; Mark Ritter; Elizabeth O'Meara; Michael J Seider; W Robert Lee; Seth A Rosenthal; Thomas Pisansky; Charles Catton; Richard K Valicenti; Anthony L Zietman; Walter R Bosch; Howard Sandler; Mark K Buyyounouski; Cynthia Ménard
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-23       Impact factor: 7.038

9.  Radiotherapy after radical prostatectomy: immediate or early delayed?

Authors:  D Bottke; D Bartkowiak; M Schrader; T Wiegel
Journal:  Strahlenther Onkol       Date:  2012-11-07       Impact factor: 3.621

10.  A Prostate Fossa Contouring Instructional Module: Implementation and Evaluation.

Authors:  Jillian R Gunther; Stanley L Liauw; Seungtaek Choi; Abdallah S R Mohamed; Nikhil G Thaker; Clifton D Fuller; Christopher J Stepaniak; Prajnan Das; Daniel W Golden
Journal:  J Am Coll Radiol       Date:  2016-05-18       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.